Cita APA

Sarabi, M., Mais, L., Oussaid, N., Desseigne, F., Guibert, P., & De La Fouchardiere, C. (2017). Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinoma. Oncol Lett.

Chicago Style Citation

Sarabi, Matthieu, Laetitia Mais, Nadia Oussaid, Françoise Desseigne, Pierre Guibert, i Christelle De La Fouchardiere. "Use of Gemcitabine As a Second-line Treatment Following Chemotherapy With Folfirinox for Metastatic Pancreatic Adenocarcinoma." Oncol Lett 2017.

Cita MLA

Sarabi, Matthieu, et al. "Use of Gemcitabine As a Second-line Treatment Following Chemotherapy With Folfirinox for Metastatic Pancreatic Adenocarcinoma." Oncol Lett 2017.